Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL
Krish Patel
Blood
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Journal of Clinical Oncology
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
New England Journal of Medicine
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia